Tag: drug eluting stents

SYNTAX Study

SYNTAX Substudy: CABG’s Edge Over PCI Extends to Long-Term QoL

Advantage is greatest in patients with the most complex disease

Abbott_absorb_scaffold_1-690

ABSORB III at Two Years: Jury’s Still Out on Bioresorbable Stent Vs. DES

Elevated risk mitigated by proper techniques in appropriately sized vessels

16-HRT-1304-IVUS-Guided-PCI-CQD-650×450

IVUS-Guided PCI in the Era of Drug-Eluting Stents

Meta-analysis proves its value, but patient risk defines its role

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

BackPage 1 of 1Next
Advertisement
Ad